Age (years) | 49.0 (12) |
African American (n, %) | 33 (54) |
Hispanic (n, %) | 16 (30) |
Women (n, %) | 21 (39) |
Diabetic (n, %) | 34 (63) |
Taking cinacalcet (n, %) | 18 (33) |
Taking calcium containing phosphate binder (n, %) | 30 (56) |
Taking non-calcium containing phosphate binder (n, %) | 22 (41) |
Receiving intradialytic vitamin D agonist | 43 (80) |
Taking angiotensin converting enzyme inhibitor (n, %) | 20 (37) |
Taking angiotensin receptor blocker (n, %) | 11 (20) |
Taking beta adrenergic receptor antagonist (n, %) | 41 (76) |
Serum calcium (mmol/L) | 2.29 (0.2) |
Serum parathyroid hormone (ng/L) | 631 (700) |
Serum phosphate (mmol/L) | 1.9 (0.6) |
Serum albumin (g/L) | 38.2 (3) |
Protein catabolic rate | 1.03 (0.3) |
Blood urea nitrogen (mmol/L) | 20.2 (7.2) |
Serum creatinine (µmol/L) | 911 (250) |
Serum potassium (mmol/L) | 4.88 (0.6) |
Kt/V | 1.46 (0.2) |
Hemoglobin (g/L) | 105 (11) |
Treatment Time (minutes) | 233 (19) |
Blood flow (mL/min() | 409 (86) |
Dialysate flow (mL/min) | 683 (110) |
Receiving 2 K bath (n, %) | 45 (83) |
Receiving 2.5 Ca bath (n, %) | 53 (98) |
Estimated dry weight (kg) | 85.8 (21) |
Percentage of interdialytic weight gain | 3.00 (1.9) |
Ultrafiltration rate (mL/kg/hr) | 8.00 (3.7) |
Pre-HD supine systolic BP (mmHg) | 164 (27) |
Pre-HD seated systolic BP (mmHg) | 158 (21) |
Post-HD seated systolic BP (mmhg) | 142 (21) |
Post-HD supine systolic BP (mmHg) | 152 (21) |
Pre-HD supine diastolic BP (mmHg) | 91.5 (17) |
Pre-HD seated diastolic BP (mmHg); | 86.1 (16) |
Post-HD seated diastolic BP (mmHg); | 78.4 (15) |
Post-HD supine diastolic BP (mmHg) | 86.4 (14) |
Mean ambulatory systolic BP (mmHg); | 144 (14) |
Mean ambulatory diastolic BP (mmHg); | 79.9 (12) |
Pre-HD TPRI (dynes*sec/cm5/m2) | 3220 (850) |
Plasma ET-1 (pg/mL) | 2.42 (1.6) |
Plasma ADMA (µmol/L) | 0.76 (0.2) |